DocGo Inc. Income (Loss) from Equity Method Investments
DocGo Inc. (DCGO) reported Income (Loss) from Equity Method Investments of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-17
- DocGo Inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was $0.00.
- DocGo Inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was $0.00.
- DocGo Inc. income (loss) from equity method investments for the quarter ending 2025-12-31 was -$446.21K.
- DocGo Inc. income (loss) from equity method investments for the quarter ending 2025-09-30 was -$27.04K.
- DocGo Inc. income (loss) from equity method investments for fiscal 2025 was -$552.76K.
- DocGo Inc. income (loss) from equity method investments for fiscal 2024 was -$316.04K.
- DocGo Inc. income (loss) from equity method investments for fiscal 2023 was -$343.34K, a 3949.49% decline from fiscal 2022.
- DocGo Inc. income (loss) from equity method investments for fiscal 2022 was $8.92K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 3 month as first filed | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $0.00 10-Q · filed 2026-08-17 | -$446.21K derived: sum of 3 quarters · filed 2026-08-17 | -$473.25K derived: sum of 4 quarters · filed 2026-08-17 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | -$446.21K derived: sum of 2 quarters · filed 2026-05-11 | -$473.25K derived: sum of 3 quarters · filed 2026-05-11 | -$512.07K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-12-31 | -$446.21K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$473.25K derived: sum of 2 quarters · filed 2026-03-16 | -$512.07K derived: sum of 3 quarters · filed 2026-03-16 | -$552.76K 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$27.04K 10-Q · filed 2025-11-10 | -$65.85K derived: sum of 2 quarters · filed 2025-11-10 | -$106.55K 10-Q · filed 2025-11-10 | -$192.67K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-06-30 | -$38.82K 10-Q · filed 2025-08-07 | -$79.52K 10-Q · filed 2026-08-17 | -$165.64K derived: sum of 3 quarters · filed 2026-05-11 | -$248.38K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-03-31 | -$40.70K 10-Q · filed 2026-05-11 | -$126.82K derived: sum of 2 quarters · filed 2026-05-11 | -$209.56K derived: sum of 3 quarters · filed 2026-05-11 | -$273.57K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$86.12K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$168.86K derived: sum of 2 quarters · filed 2026-03-16 | -$232.88K derived: sum of 3 quarters · filed 2026-03-16 | -$316.04K 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$82.74K 10-Q · filed 2025-11-10 | -$146.76K derived: sum of 2 quarters · filed 2025-11-10 | -$229.92K 10-Q · filed 2025-11-10 | -$271.90K derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-06-30 | -$64.01K 10-Q · filed 2025-08-07 | -$147.18K 10-Q · filed 2025-08-07 | -$189.16K derived: sum of 3 quarters · filed 2026-03-16 | -$284.66K derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-03-31 | -$83.17K 10-Q · filed 2025-05-08 | -$125.14K derived: sum of 2 quarters · filed 2026-03-16 | -$220.64K derived: sum of 3 quarters · filed 2026-03-16 | -$311.22K derived: sum of 4 quarters · filed 2026-03-16 | |
| 2023-12-31 | -$41.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$137.48K derived: sum of 2 quarters · filed 2026-03-16 | -$228.05K derived: sum of 3 quarters · filed 2026-03-16 | -$343.34K 10-K · filed 2026-03-16 | |
| 2023-09-30 | -$95.50K 10-Q · filed 2024-11-07 | -$186.08K derived: sum of 2 quarters · filed 2024-11-07 | -$301.36K 10-Q · filed 2024-11-07 | -$392.28K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$90.57K 10-Q · filed 2024-08-07 | -$205.86K 10-Q · filed 2024-08-07 | -$296.78K derived: sum of 3 quarters · filed 2025-02-27 | -$203.41K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$115.29K 10-Q · filed 2024-05-08 | -$206.21K derived: sum of 2 quarters · filed 2025-02-27 | -$112.84K derived: sum of 3 quarters · filed 2025-02-27 | $795.00 derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$90.92K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.45K derived: sum of 2 quarters · filed 2025-02-27 | $116.08K derived: sum of 3 quarters · filed 2025-02-27 | $8.92K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $93.37K 10-Q · filed 2023-11-06 | $207.00K derived: sum of 2 quarters · filed 2023-11-06 | $99.84K 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $113.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $30.29K 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$83.34K 10-Q · filed 2023-05-09 | -$69.00K 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | -$66.82K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |